Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

EMBO Reports

Volumn 7, Issue 9, 2006, Pages 940-946

  Radde, Rebecca ^a   Bolmont, Tristan ^a   Kaeser, Stephan A ^a   Coomaraswamy, Janaky ^a   Lindau, Dennis ^a   Stoltze, Lars ^a   Calhoun, Michael E ^a   Jäggi, Fabienne ^a   Wolburg, Hartwig ^c   Gengler, Simon ^d   Haass, Christian ^e   Ghetti, Bernardino ^f   Czech, Christian ^g   Hölscher, Christian ^d   Mathews, Paul M ^h   Jucker, Mathias ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF ULSTER   (United Kingdom)

^e UNIVERSITY OF MUNICH   (Germany)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g F HOFFMANN LA ROCHE LTD   (Switzerland)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN; PRESENILIN 1; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PSEN1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING; CELL COUNT; CONTROLLED STUDY; DENTATE GYRUS; DISEASE PREDISPOSITION; GENETIC ENGINEERING; GLIOSIS; MICROGLIA; MOUSE; NEOCORTEX; NEURITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS; ANIMAL; C57BL MOUSE; COGNITION; DISEASE MODEL; EVALUATION; GENETICS; INFLAMMATION; MALE; METABOLISM; NERVE CELL; PATHOLOGY;

MUS MUSCULUS;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL AMYLOID ANGIOPATHY; COGNITION; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOCORTEX; NEURONS; PEPTIDE FRAGMENTS; PRESENILIN-1;

EID: 33748988258     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400784     Document Type: Article

References (31)

1. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, Esselmann H, De Strooper B (2006) Presenilin clinical mutations can affect γ-secretase activity by different mechanisms. J Neurochem 96: 732-742
2. Bondolfi L, Calhoun M, Ermini F, Kuhn HG, Wiederhold KH, Walker L, Staufenbiel M, Jucker M (2002) Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci 22: 515-522
3. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19: 939-945
4. Buzsaki G, Bors L, Nagy F, Eidelberg E (1982) Spatial mapping, working memory, and the fimbria-fornix system. J Comp Physiol Psychol 96: 26-34
5. Calhoun ME, Wiederhold KH, Abramowski D, Phinney AL, Probst A, Sturchler-Pierrat C, Staufenbiel M, Sommer B, Jucker M (1998) Neuron loss in APP transgenic mice. Nature 395: 755-756
6. Casas C et al (2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Ab42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165: 1289-1300
7. Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F (2004) Inflammation occurs early during the Aβ deposition process in TgCRND8 mice. Neurobiol Aging 25: 861-871
8. Duering M, Grimm MO, Grimm HS, Schroder J, Hartmann T (2005) Mean age of onset in familial Alzheimer's disease is determined by amyloid β 42. Neurobiol Aging 26: 785-788
9. Ezquerra M, Carnero C, Blesa R, Oliva R (2000) A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease. Arch Neurol 57: 485-488
10. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM (1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 152: 307-317
11. Herzig MC et al (2004) Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7: 954-960
12. Holcomb L et al (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97-100
13. Holscher C, Schmid S, Pilz PK, Sansig G, van der Putten H, Plappert CF (2004) Lack of the metabotropic glutamate receptor subtype 7 selectively impairs short-term working memory but not long-term memory. Behav Brain Res 154: 473-481
14. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274: 99-102
15. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) APPSw transgenic mice develop age-related A β deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56: 965-973
16. Jucker M, Ingram DK (1997) Murine models of brain aging and age-related neurodegenerative diseases. Behav Brain Res 85: 1-26
17. Kumar-Singh S et al (2006) Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Hum Mutat 27: 686-695
18. Lehman EJ et al (2003) Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse. Hum Mol Genet 12: 2949-2956
19. Long JM, Kalehua AN, Muth NJ, Calhoun ME, Jucker M, Hengemihle JM, Ingram DK, Mouton PR (1998) Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol Aging 19: 497-503
20. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J Neurosci 16: 5795-5811
21. Matsuoka Y et al (2001) Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol 158: 1345-1354
22. McGowan E et al (2005) Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47: 191-199
23. Moehlmann T et al (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ 42 production. Proc Natl Acad Sci USA 99: 8025-8030
24. Pantieri R, Pardini M, Cecconi M, Dagna-Bricarelli F, Vitali A, Piccini A, Russo R, Borghi R, Tabaton M (2005) A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. Neurol Sci 26: 349-350
25. Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, Staufenbiel M, Jucker M (1999) Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 19: 8552-8559
26. Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K (1992) Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn 18: 70-87
27. Selkoe DJ, Schenk D (2003) Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43: 545-584
28. Siman R, Reaume AG, Savage MJ, Trusko S, Lin YG, Scott RW, Flood DG (2000) Presenilin-1 P264L knock-in mutation: Differential effects on Aβ production, amyloid deposition, and neuronal vulnerability. J Neurosci 20: 8717-8726
29. Stalder AK et al (2005) Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 25: 11125-11132
30. Sturchler-Pierrat C et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94: 13287-13292
31. Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman BT (2002) Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci USA 99: 13990-13995